Opportunity Information: Apply for PAR 21 264
The National Institutes of Health, through the National Institute of Mental Health (NIMH), is offering a discretionary grant opportunity titled "Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)" under Funding Opportunity Number PAR 21 264 (CFDA 93.242). This announcement is a reissue of an earlier solicitation (RFA-MH-19-240) and uses the NIH R21 mechanism, which is generally designed to support early-stage, exploratory, or high-impact developmental research. The clinical trial component is optional, meaning applicants may propose work that does not involve a clinical trial, but they can also include certain trial-like elements if appropriate and consistent with NIH definitions and requirements.
The core goal of the program is to push psychiatry and mental health research toward more precise, computationally grounded measurements of behavior. NIMH is specifically looking for projects that apply computational approaches to create parametrically detailed behavioral assays. In practical terms, the agency wants tasks, paradigms, or assessment frameworks where behavior can be measured in a fine-grained way and mapped onto formal computational models with interpretable parameters. These behavioral assays should cover domains of function that are relevant to mental health, which can include areas like decision-making, learning, reward processing, cognitive control, social interaction, affective processing, perception, motivation, or other functional domains tied to psychiatric risk and resilience.
A key emphasis in this FOA is that the work should focus on human behavior and should test computational models in healthy subjects. The intent here is to establish strong foundational measures and model-based parameters in well-characterized non-clinical samples, where confounds related to illness state, medication, or chronic impairment are minimized. By validating the tasks and computational interpretations in healthy participants first, researchers can create clearer benchmarks for what "typical" parameter distributions look like and can better understand reliability, sensitivity, and the specific behavioral signatures their models capture.
NIMH also signals a strong forward-looking translational motivation. For future applications, the institute is particularly interested in behavioral measures, computational models, and model parameters that can be back-translated from humans to animals. This means the agency is encouraging investigators to design behavioral assays and computational constructs that can be implemented in analogous forms in animal models, so that the same kinds of computational readouts can be compared across species. The larger strategic value of this is to strengthen pre-clinical therapeutics development by linking animal work more directly to human-relevant behavioral constructs, rather than relying only on broad symptom proxies. In addition, NIMH notes interest in models that can be extended to clinical populations in the future, even if the immediate proposed studies focus on healthy participants. In other words, applicants should be thinking ahead about how their tasks and parameters could eventually be used to characterize psychiatric populations, stratify individuals, track treatment effects, or connect behavior to mechanisms.
Eligibility is broad and includes many common U.S. applicant types such as state, county, and local governments; public and state-controlled and private institutions of higher education; independent school districts; special district governments; and public housing authorities/Indian housing authorities. The opportunity is also open to federally recognized Native American tribal governments and other Native American tribal organizations, as well as nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education), for-profit organizations (other than small businesses), and small businesses. The FOA explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). This breadth suggests NIMH is aiming to attract a wide range of methodological expertise and populations, including applicants positioned to bring diverse perspectives and settings to computational behavioral measurement work.
From the published source data, the original closing date listed for this opportunity was 2023-09-25, and the announcement was created on 2021-07-07. The award ceiling and expected number of awards are not specified in the provided details, which is not unusual in some summaries and typically means applicants should consult the full FOA text and NIH budget guidance for allowable costs, project period expectations, and any institute-specific funding considerations. Overall, this program is best understood as an invitation to build and rigorously test computationally explicit behavioral assays in humans, generate interpretable model parameters tied to mental-health relevant functioning, and do so in a way that supports eventual cross-species translation and later extension into clinical research and therapeutics development.Apply for PAR 21 264
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2021-07-07.
- Applicants must submit their applications by 2023-09-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: USGS Earthquake Hazards Program External Research Support Announcement for Fiscal Year 2023
Previous opportunity: Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 21 264
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 21 264) also looked into and applied for these:
| Funding Opportunity |
|---|
| Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) Apply for RFA HG 21 001 Funding Number: RFA HG 21 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed) Apply for RFA HG 21 002 Funding Number: RFA HG 21 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Making Health Care Safer in Ambulatory Care Settings and Long-term Care Facilities (R18) Apply for PA 21 267 Funding Number: PA 21 267 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01) Apply for PA 22 047 Funding Number: PA 22 047 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) Apply for PAR 21 239 Funding Number: PAR 21 239 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18) Apply for PA 22 048 Funding Number: PA 22 048 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) Apply for RFA AI 21 050 Funding Number: RFA AI 21 050 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) Apply for RFA RM 21 025 Funding Number: RFA RM 21 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed) Apply for RFA AG 22 021 Funding Number: RFA AG 22 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Aging Research in Animals (ARIA): Promoting Rigorous Research on Behavioral and Social Processes (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 22 015 Funding Number: RFA AG 22 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Required) Apply for RFA AG 22 024 Funding Number: RFA AG 22 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional) Apply for PAR 21 265 Funding Number: PAR 21 265 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) Apply for PAR 21 276 Funding Number: PAR 21 276 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) Apply for PAR 21 267 Funding Number: PAR 21 267 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) Apply for PAR 21 258 Funding Number: PAR 21 258 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) Apply for PAR 21 266 Funding Number: PAR 21 266 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Data Management and Coordinating Center (DMCC) and a Collaborative Research Space for Translational Research on Exceptional Longevity (U24 Clinical Trial Not Allowed) Apply for RFA AG 22 023 Funding Number: RFA AG 22 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) Apply for PAR 21 289 Funding Number: PAR 21 289 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) Apply for PAR 21 288 Funding Number: PAR 21 288 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Materials to Enhance Training in Experimental Rigor (METER) (UE5 Clinical Trial Not Allowed) Apply for RFA NS 21 033 Funding Number: RFA NS 21 033 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 264", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
